Trpc6-transgenic mice with an elevated basal level of TRPC6 expression are less susceptible to cerebral ischemia than their wild-type littermates and have lower mortality rates, reduced infarct volumes, and better neurological outcomes after middle cerebral artery occlusion (MCAO) [16]. This evidence concerns the gene TRPC6 and brain ischemia.